On the afternoon of August 15, Tianjin Bank leaders visited the TTGG .Zhang Yu, managing partner of our company, Zhou Jufeng, director of risk control, Fu Xiong, deputy director of the president's office, He Yichao, Liu Zhichao, product manager of the fund management department, and other relevant personnel attended the forum. .At the meeting, Director Fu expressed warm welcome to the leaders of the Bank of Tianjin and introduced the development history, standard management and business development of our company. Afterwards, Mr. Zhang said that TTGG has a natural complementary relationship wi...
Release time:
2018
-
08
-
17
浏览次数：26
With the implementation of the new policy, the barbaric growth period of the network car is no longer. Nowadays, the growth of user scale has entered a stable period, seeking diversified development, integrating resources, and cross-border cooperation has become the mainstream trend of network-based car companies to explore competitive advantages at this stage. For example, it is more common to connect the network car platform to the railway booking system and access the travel brand client.The network car companies are expanding into many fields, and the development of investment in new busin...
Release time:
2018
-
08
-
16
浏览次数：108
On August 9th, the 20th Guangdong Enterprises Top 500 and Excellent Independent Brands Release Conference was held in Guangzhou. Vice Governor of Guangdong Province Chen Liangxian attended the conference and delivered a speech. Kangmei Pharmaceutical ranks 66th among the “Top 500 Enterprises in Guangdong in 2018”, which is two places higher than last year. It ranks among the top 100 for the sixth consecutive year. At the same time, Kangmei Pharmaceutical is also listed in the "Top 100 Guangdong Manufacturing Enterprises" and "Top 100 Private Enterprises in Guangdong" list, ...
Release time:
2018
-
08
-
15
浏览次数：20
Jiansheng Group (603558) released the 2018 semi-annual report on the evening of August 6. During the reporting period, the company achieved a total operating income of 757 million yuan, a year-on-year increase of 64.47%; the net profit attributable to shareholders of listed companies was 110 million yuan, an increase of 69.89%. During the reporting period, the company consolidated and developed the export market and actively developed new customers. The European market in the sales region has grown steadily, with Australia and the Americas showing rapid growth. In terms of seamless underw...
Release time:
2018
-
08
-
10
浏览次数：19
Kangmei Pharmaceutical (600518) announced on the evening of August 2 that the company signed the "Medical Investment Cooperation Agreement" with Tongliao State-owned Capital Investment Operation Co., Ltd. and Tongliao City Hospital. The three parties will jointly invest in the construction of "Kangmei Tongliao Hospital" to create a three-level linkage. The medical consortium integrates the construction of a regional medical health center in the northeastern Inner Mongolia. The partner plans to invest 2.5 billion yuan to invest in the new hospital area of Tongliao City Hospi...
Release time:
2018
-
08
-
09
浏览次数：16